Medtech company Brainlab AG announced plans to conduct an IPO on the Frankfurt Stock Exchange, becoming the latest German company to seek listing this year. The Munich-based company plans to list on regulated markets within the next few weeks, according to a statement on Thursday. The company said the capital increase of up to 200 million euros will be used to fund growth plans and strengthen balance sheets and sales teams. The offering will also include second-tier shares, but the announcement did not specify the number of shares to be issued. Brainlab develops software that makes surgery and cancer treatment more accurate, data-driven, and less invasive. It also helps hospitals plan and guide medical procedures.

Medtech company Brainlab AG announced plans to conduct an IPO on the Frankfurt Stock Exchange, becoming the latest German company to seek listing this year. The Munich-based company plans to list on regulated markets within the next few weeks, according to a statement on Thursday. The company said the capital increase of up to 200 million euros will be used to fund growth plans and strengthen balance sheets and sales teams. The offering will also include second-tier shares, but the announcement did not specify the number of shares to be issued. Brainlab develops software that makes surgery and cancer treatment more accurate, data-driven, and less invasive. It also helps hospitals plan and guide medical procedures.